The aim of this ESC Guideline is to help health professionals manage people with heart
failure (HF) according to the best available evidence. Fortunately, we now have a wealth of …

Abstract Document Reviewers: Rudolf A. de Boer (CPG Review Coordinator)(Netherlands),
P. Christian Schulze (CPG Review Coordinator)(Germany), Magdy Abdelhamid (Egypt) …

Right ventricular dysfunction is a major determinant of outcome in patients with complex
congenital heart disease, as in tetralogy of Fallot. In these patients, right ventricular …

Background: Sacubitril/valsartan was demonstrated to reduce hospitalization rate and
mortality in patients with heart failure with reduced ejection fraction. Data on the effects of …

Background Heart failure is an important cause of morbidity and mortality in adults with
congenital heart disease (ACHD). Sacubitril/valsartan is an established treatment for heart …

Abstract Purpose of Review This paper reviews the latest literature on the growing field of
heart failure in the adult congenital heart disease population. Recent Findings After …

Objective Patients with a systemic right ventricle (sRV) in the context of transposition of the
great arteries (TGA) after atrial switch or congenitally corrected TGA (ccTGA) are prone to …

Heart failure with reduced ejection fraction (HFrEF) is common in patients with adult
congenital heart disease. Many of the most common congenital defects have a high …

Since the original description, the Fontan operation has been widely used for the palliation
of children with single ventricle physiology. Although the Fontan operation revolutionized the …

Introduction: Advancements in surgery and management have resulted in a growing
population of aging adults with tetralogy of Fallot (TOF). As a result, there has been a …